Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study
Authors:
- Emanuel K ManesisEMEmanuel K Manesis
- Anastasia PapakonstantinouAPAnastasia Papakonstantinou
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 31 (2) , 210-214
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Ganciclovir Treatment of Active Hepatitis B Virus Infection in a Heart Transplant PatientJournal of Clinical Gastroenterology, 1996
- Ganciclovir treatment of hepatitis B virus infection in liver transplant recipientsHepatology, 1996
- Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDSNew England Journal of Medicine, 1995
- Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patientsClinical Therapeutics, 1995
- ATTEMPTED RESOLUTION OF ACUTE RECURRENT HEPATITIS B IN A TRANSPLANTED LIVER ALLOGRAFT BY THE ADMINISTRATION OF GANCICLOVIRTransplantation, 1994
- Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infectionJournal of Gastroenterology and Hepatology, 1993
- Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antiviralsClinical and Diagnostic Virology, 1993
- Inhibition of Duck Hepatitis B Virus Replicationin vivoby the Nucleoside Analogue Ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] Guanine)Antiviral Chemistry and Chemotherapy, 1991
- INHIBITION OF HBV DNA REPLICATION BY GANCICLOVIR IN PATIENTS WITH AIDSThe Lancet, 1989
- Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replicationAntimicrobial Agents and Chemotherapy, 1984